Literature DB >> 31929513

IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Christian Lundtoft1, Julia Seyfarth1, Marc Jacobsen2.   

Abstract

Interleukin-7 receptor α chain (IL-7Rα) single nucleotide polymorphisms (SNPs) are associated with susceptibility to immunopathologies like autoimmune and inflammatory diseases. The current hypothesis about underlying mechanisms is based on the regulation of IL-7 availability for self-reactive T cells by influencing the generation of a soluble (s)IL-7Rα variant. This assumption was mainly predicated on the well-defined IL7RA SNP rs6897932, which affects alternative splicing and causes aberrant generation of the sIL-7Rα variant with potential effects on the IL-7 serum reservoir. However, more recent studies shed light on novel functions of autoimmunity risk-associated IL7RA SNPs and characterized the largely neglected effect of rs6897932 on membrane (m)IL-7Rα expression. These findings as well as a described role of impaired mIL-7Rα expression and IL7RA SNP influence on chronic infectious diseases necessitates the reevaluation of previous findings on the role of IL7RA SNPs in immunopathology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31929513     DOI: 10.1038/s41435-019-0091-y

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  80 in total

Review 1.  Interleukin-7 receptor expression: intelligent design.

Authors:  Renata Mazzucchelli; Scott K Durum
Journal:  Nat Rev Immunol       Date:  2007-02       Impact factor: 53.106

Review 2.  The human IL-7 receptor gene: deletions, polymorphisms and mutations.

Authors:  Renata I Mazzucchelli; Agostino Riva; Scott K Durum
Journal:  Semin Immunol       Date:  2012-03-17       Impact factor: 11.130

3.  Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function.

Authors:  Li-Fen Lee; Kathryn Logronio; Guang Huan Tu; Wenwu Zhai; Irene Ni; Li Mei; Jeanette Dilley; Jessica Yu; Arvind Rajpal; Colleen Brown; Charles Appah; Sherman Michael Chin; Bora Han; Timothy Affolter; John C Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

4.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

5.  Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.

Authors:  A Puel; S F Ziegler; R H Buckley; W J Leonard
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

6.  Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.

Authors:  Sarita A Y Hartgring; Cynthia R Willis; Dina Alcorn; Laurel J Nelson; Johannes W J Bijlsma; Floris P J G Lafeber; Joel A G van Roon
Journal:  Arthritis Rheum       Date:  2010-09

7.  IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.

Authors:  Cristina Penaranda; Wilson Kuswanto; Jerry Hofmann; Rupert Kenefeck; Parth Narendran; Lucy S K Walker; Jeffrey A Bluestone; Abul K Abbas; Hans Dooms
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

8.  Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.

Authors:  Chen Shochat; Noa Tal; Obul R Bandapalli; Chiara Palmi; Ithamar Ganmore; Geertruy te Kronnie; Gunnar Cario; Giovanni Cazzaniga; Andreas E Kulozik; Martin Stanulla; Martin Schrappe; Andrea Biondi; Giuseppe Basso; Dani Bercovich; Martina U Muckenthaler; Shai Izraeli
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

9.  Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.

Authors:  Rosana Gonzalez-Quintial; Brian R Lawson; John C Scatizzi; Joseph Craft; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

10.  IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates.

Authors:  Lyssia Belarif; Caroline Mary; Lola Jacquemont; Hoa Le Mai; Richard Danger; Jeremy Hervouet; David Minault; Virginie Thepenier; Veronique Nerrière-Daguin; Elisabeth Nguyen; Sabrina Pengam; Eric Largy; Arnaud Delobel; Bernard Martinet; Stéphanie Le Bas-Bernardet; Sophie Brouard; Jean-Paul Soulillou; Nicolas Degauque; Gilles Blancho; Bernard Vanhove; Nicolas Poirier
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

View more
  3 in total

1.  Synergistic insights into human health from aptamer- and antibody-based proteomic profiling.

Authors:  Maik Pietzner; Eleanor Wheeler; Julia Carrasco-Zanini; Nicola D Kerrison; Erin Oerton; Mine Koprulu; Jian'an Luan; Aroon D Hingorani; Steve A Williams; Nicholas J Wareham; Claudia Langenberg
Journal:  Nat Commun       Date:  2021-11-24       Impact factor: 14.919

2.  IL-7/IL7R axis dysfunction in adults with severe community-acquired pneumonia (CAP): a cross-sectional study.

Authors:  Sandra Ampuero; Guillermo Bahamonde; Fabián Tempio; María Luisa Garmendia; Mauricio Ruiz; Rolando Pizarro; Patricio Rossi; Lucía Huenchur; Luis Lizama; Mercedes López; Luis F Avendaño; Vivian Luchsinger
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

3.  Genetic association and Mendelian randomization for hypothyroidism highlight immune molecular mechanisms.

Authors:  Samuel Mathieu; Mewen Briend; Erik Abner; Christian Couture; Zhonglin Li; Yohan Bossé; Sébastien Thériault; Tõnu Esko; Benoit J Arsenault; Patrick Mathieu
Journal:  iScience       Date:  2022-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.